A prospective, interventional, single group study to evaluate safety and effectiveness of an Ayurvedic regimen as an add on treatment in hospitalized SARS-CoV2 tested positive pre-symptomatic, mild or moderate COVID-19 cases - COVID-19

Aarti Foundation Mumbai and Kutchhi Jain Foundation Mumbai0 个研究点目标入组 61 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•1. Individuals of either sex above 18
•2. People who have been tested positive to be infected with SARS-CoV2 virus and presenting with no symptoms or mild to moderate symptoms.
•3. Subject who agrees for giving informed consent and provide signed and dated written IEC approved Informed Consent Form (ICF) prior to initiation of any study procedures

•1. Subjects who are not able to or not willing to sign an IRB/IEC approved consent form.
•2. COVID patients with symptoms classified as severe or critical.
•3. Persons with severe primary respiratory disease or other pneumonia
•4. Pregnant women
•5. Persons with serious complications of diseases such as cancer, heart disease, stroke, disabilities, mental illnesses, etc., and who are considered to be excluded from the study as evaluated by the investigators
•6. COVID-19 positive cases participating as subjects in the interventional arm of other COVID-19 clinical trials

发起方

Aarti Foundation Mumbai and Kutchhi Jain Foundation Mumbai